Cost Analysis of Noninvasive Helmet Ventilation Compared with Use of Noninvasive Face Mask in ARDS
Intensive care unit (ICU) costs have doubled since 2000, totalling 108 billion dollars per year. Acute respiratory distress syndrome (ARDS) has a prevalence of 10.4% and a 28-day mortality of 34.8%. Noninvasive ventilation (NIV) is used in up to 30% of cases. A recent randomized controlled trial by...
Main Authors: | Kwadwo Kyeremanteng, Louis-Philippe Gagnon, Raphaëlle Robidoux, Kednapa Thavorn, Dipayan Chaudhuri, Daniel Kobewka, John P. Kress |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2018/6518572 |
Similar Items
-
The noninvasive ventilation helmet: Another vital tool for the new normal
by: Arjun Khanna, et al.
Published: (2021-01-01) -
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation
by: Francesco Menzella, et al.
Published: (2020-09-01) -
A Rare Case of ARDS Caused by Bupropion Inhalation and Treated with Noninvasive Ventilation
by: Yousif Al-Saiegh, et al.
Published: (2020-01-01) -
External dental fistula due to face mask used in noninvasive positive pressure ventilation
by: Takaharu Ikeda, et al.
Published: (2020-10-01) -
Noninvasive Ventilation
Published: (2010-01-01)